OpenAlex
PricingAboutJobs
Log inGet started
Work

Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 Diabetes

HTML

Year: 2015
Type: article
Study design: Case Report
Source: Diabetes Care
DOI: 10.2337/dc15-1331
Authors: Caroline Gaudy, Céline Clévy, Sandrine Monestier, Noémie Dubois, Yanis Préau, Stéphanie Mallet, Marie-Aleth Richard, Jean-Jacques Grob, René Valéro, Sophie Béliard
Institutions: Inserm, Assistance Publique Hôpitaux de Marseille, Hôpital de la Timone, Hôpital de la Conception, Aix-Marseille Université, Institut National de la Recherche Agronomique
Language: English

Topic: Diabetes and associated disorders
Subfield: Genetics
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: pembrolizumab, anti-PD-1 therapy, fulminant type 1 diabetes, immune checkpoint inhibitors, drug-induced diabetes, diabetic ketoacidosis, acute kidney injury, C-peptide, glutamic acid decarboxylase antibodies, anti-IA-2 antibodies
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1725918626
FWCI: 12.36
Cites: 5
Cited by: 164
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security